Found 103 matching trials
Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02 NA RATIONALE: Gathering information over time from bone density and laboratory...
Show More Location
Royal Brisbane and Women's Hospital
Learn More & Join Trial
Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer PHASE2 This research study is evaluating a drug called Palbociclib in combination ...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis PHASE2 This phase II trial studies how well radiation therapy given with standard ...
Show More Location
Grady Health System
Learn More & Join Trial
T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer PHASE1 This phase Ib trials studies the side effects and how well talimogene laher...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma PHASE2 Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Pharmacology of Adjuvant Hormonotherapy in Breast Cancer PHASE4 This is a biomedical study of interventional type, multicenter, inter-regio...
Show More Learn More & Join Trial
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer PHASE3 RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormon...
Show More Location
Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center
Learn More & Join Trial
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer PHASE2 This phase II trial tests the accuracy of functional imaging (FFNP)-positro...
Show More Location
Siteman Cancer Center at Washington University
Learn More & Join Trial
Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer PHASE2 Primary Objective:
To determine whether amcenestrant per overall survival ...
Show More Location
Alabama Oncology - St. Vincent's Birmingham- Site Number : 8400008
Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer) PHASE3 This Phase III, randomized, open-label, multicenter study will evaluate the...
Show More Status
Active Not Recruiting
Location
Alaska Oncology & Hematology, LLC
Learn More & Join Trial